Precision Oncology Market to Surpass USD 190.46 Billion by 2030

◉ Precision Oncology Market to Surpass USD 190 Billion by 2030, Driven by Genomic Innovations and Strategic Collaborations

The global precision oncology market is projected to grow from USD 98.36 billion in 2023 to approximately USD 190.46 billion by 2030, registering a robust CAGR of 9.9%. This growth is fueled by advancements in genomic sequencing, personalized medicine approaches, and increasing investments in targeted cancer therapies.​

Grab your sample copy of this report now: https://www.maximizemarketresearch.com/request-sample/188401/

◉ Precision Oncology Market Competitive Landscape

Leading companies in the precision oncology sector include Foundation Medicine, Guardant Health, Illumina, Inc., Roche Molecular Systems, and Tempus Labs. These organizations are at the forefront of developing innovative diagnostic tools and therapeutic solutions, contributing significantly to market expansion.​

◉ Precision Oncology Market Country-Specific Insights

Growth Opportunities in Vietnam

Vietnam is emerging as a potential market for precision oncology, with increasing awareness and investments in healthcare infrastructure. Collaborations with international organizations aim to enhance cancer care and research capabilities in the region.​

Market Trends in Thailand

Thailand's precision oncology market is witnessing growth due to government initiatives promoting personalized medicine and the integration of advanced diagnostic technologies in healthcare facilities.​

Excited to dive in? Request your sample copy of the report to uncover its contents: https://www.maximizemarketresearch.com/request-sample/188401/

Innovation Growth in Japan

Japan's precision oncology market is anticipated to grow at a significant CAGR, driven by substantial investments in research and development, particularly in biotechnology and diagnostics. In April 2024, Ono Pharmaceutical Co. announced the acquisition of U.S.-based Deciphera Pharmaceuticals for $2.4 billion, aiming to expand its oncology portfolio and presence in the U.S. and Europe. ​

Consolidation Trends in South Korea

South Korea is focusing on consolidating its position in the precision oncology market through investments in advanced research facilities and fostering partnerships between public and private sectors to develop innovative cancer treatments.​

Updation Trends in Singapore

Singapore is updating its healthcare strategies to incorporate precision oncology, emphasizing the development of personalized treatment plans and the integration of genomic data into clinical practice.​

Market Opportunities in the United States

The United States leads the global precision oncology market, supported by advanced healthcare infrastructure and substantial investments in research and development. In August 2024, Illumina Inc. received FDA approval for its TruSight Oncology comprehensive test, analyzing over 500 genes in solid tumors to identify actionable biomarkers, enhancing the precision of cancer care. ​

For additional resources and details on this research, check out: https://www.maximizemarketresearch.com/request-sample/188401/

Expansion Trends in Europe

Europe's precision oncology market is expanding, with countries like Germany, the United Kingdom, France, and Switzerland contributing significantly due to strong healthcare systems, research capabilities, and government initiatives promoting precision medicine. ​

◉ Precision Oncology Market Mergers & Acquisitions

In July 2023, NeoGenomics expanded its global presence through strategic acquisitions in Europe and Asia, positioning itself as a prominent provider of cancer testing services. ​

In April 2024, Ono Pharmaceutical Co. acquired U.S.-based Deciphera Pharmaceuticals for $2.4 billion, aiming to enhance its oncology portfolio and expand its presence in the U.S. and European markets. ​
Reuters

◉ Precision Oncology Market Segmentation :

by Products

Diagnostics
Therapeutics

by Cancer Types

Breast Cancer
Lung Cancer
Cervical cancer
Colorectal Cancer
Prostate Cancer

by End User

Pharmaceutical & Biotechnology Companies
Diagnostic Centres
Healthcare Data Companies

Fascinated by market trends? Explore the research report summary for valuable information: https://www.maximizemarketresearch.com/market-report/precision-oncology-market/188401/

◉ Key Recent Developments

In June 2023, Illumina launched new sequencing instruments and data analysis tools, reinforcing its commitment to advancing genomic solutions for personalized cancer care. ​

The Asia-Pacific region is experiencing rapid growth in the precision oncology market, with initiatives like the Quad Cancer Moonshot by the United States, Australia, India, and Japan aiming to enhance cancer care and research collaborations in the Indo-Pacific. ​

◉ Get Market Research Latest Trends:

Global Nucleic Acid Labeling Market https://www.maximizemarketresearch.com/market-report/global-nucleic-acid-labeling-market/100798/

Bionics Market https://www.maximizemarketresearch.com/market-report/global-bionics-market/44070/

Feed Yeast Market https://www.maximizemarketresearch.com/market-report/feed-yeast-market/122115/

Global Custom Antibody Market https://www.maximizemarketresearch.com/market-report/global-custom-antibody-market/34046/

Digital PCR (dPCR) and Realtime PCR (qPCR) Market https://www.maximizemarketresearch.com/market-report/global-digital-pcr-dpcr-and-real-time-pcr-qpcr-market/32992/

Global Rapid Microbiology Testing Market https://www.maximizemarketresearch.com/market-report/global-rapid-microbiology-testing-market/21018/

Global Geriatric Medicines Market https://www.maximizemarketresearch.com/market-report/global-geriatric-medicines-market/39382/

Global Downstream Processing Market https://www.maximizemarketresearch.com/market-report/global-downstream-processing-market/20673/

Whole Exome Sequencing Market https://www.maximizemarketresearch.com/market-report/whole-exome-sequencing-market/220646/

Global Potassium Fertilizers Market https://www.maximizemarketresearch.com/market-report/global-potassium-fertilizers-market/31011/

Eurotransplant Organ Preservation Market https://www.maximizemarketresearch.com/market-report/eurotransplant-organ-preservation-market/55757/

Next-Generation Sequencing Data Analysis Market https://www.maximizemarketresearch.com/market-report/next-generation-sequencing-data-analysis-market/100220/

Global Cell Therapy Technologies Market https://www.maximizemarketresearch.com/market-report/global-cell-therapy-technologies-market/31531/

Nucleic Acid Therapeutics Market https://www.maximizemarketresearch.com/market-report/nucleic-acid-therapeutics-market/259289/

Technetium-99m Market https://www.maximizemarketresearch.com/market-report/technetium-99m-market/258480/

◉ Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

◉ Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

◉ About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.